# Lurasidone

## Latuda 40mg

| 藥物代碼 | OLAT |
| :--- | :--- |
| 適應症 | Schizophrenia. |
| 副作用 | Akathisia, somnolence. Hypersensitivity; increased wt; insomnia, agitation, anxiety, restlessness; parkinsonism, dizziness, dystonia, dyskinesia; nausea, vomiting, dyspepsia, salivary hypersecretion, upper abdominal pain, stomach discomfort; rash, pruritus; musculoskeletal stiffness, increased blood creatine phoshokinase; increased serum creatinine; fatigue. |
| 禁忌 | Hypersensitivity. Concomitant w/ strong CYP3A4 inhibitors \(eg, ketoconazole, clarithromycin, ritonavir, voriconazole\) & inducers \(eg, rifampin, St. John's wort, phenytoin, carbamazepine\). |
| 藥物保存方式 | 室溫 |
| 用法用量 | Initially 40 mg once daily. Max: 160 mg/day. Should be taken with food. |
| 肝功能異常 | 需 調 整 劑 量  Moderate impairment \(Child-Pugh class B\): Initial: 20 mg daily; maximum: 80 mg/day Severe impairment \(Child-Pugh class C\): Initial: 20 mg daily; maximum: 40 mg/day |
| 腎功能異常 | 需 調 整 劑 量 |
| 懷孕用藥危分級 | 尚未確立 |
| 孕期用藥建議 | N/A |
| 附帶說明 | No Human Data—Potential Risk in 3rd Trimester |
| 哺乳期用藥建議 | No \(Limited\) Human Data - Potential Toxicity 無\(很少\)資料 - 避免使用 |
| 附帶說明 | N/A |
| 注射劑給藥建議途徑 | N/A |
| 乾粉稀釋液 | N/A |
| 輸注點滴液 | N/A |
| IVP 用法建議 | N/A |
| IVD 用法建議 | N/A |
| 注意事項 | N/A |

